These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38625929)

  • 1. Prevalence of Dysbetalipoproteinemia in the UK Biobank According to Different Diagnostic Criteria.
    Paquette M; Trinder M; Guay SP; Brunham LR; Baass A
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38625929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE Deficiency.
    Paquette M; Bernard S; Paré G; Baass A
    J Clin Endocrinol Metab; 2022 Jan; 107(2):538-548. PubMed ID: 34467996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified diagnosis algorithm for dysbetalipoproteinemia.
    Paquette M; Bernard S; Blank D; Paré G; Baass A
    J Clin Lipidol; 2020; 14(4):431-437. PubMed ID: 32631794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype.
    Bea AM; Cenarro A; Marco-Bened V; Laclaustra M; Martn C; Ibarretxe D; Pint X; Arrobas T; Vials C; Civeira F; Olmos S
    Clin Chem; 2023 Feb; 69(2):140-148. PubMed ID: 36644927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of remnant hyperlipidaemia.
    Paquette M; Bernard S; Baass A
    Curr Opin Lipidol; 2022 Aug; 33(4):227-230. PubMed ID: 35942808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease.
    Paquette M; Bernard S; Baass A
    J Clin Endocrinol Metab; 2022 Dec; 108(1):184-190. PubMed ID: 36056815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglycerides, hypertension, and smoking predict cardiovascular disease in dysbetalipoproteinemia.
    Paquette M; Bernard S; Paré G; Baass A
    J Clin Lipidol; 2020; 14(1):46-52. PubMed ID: 31959563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder.
    Koopal C; Marais AD; Visseren FL
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):133-139. PubMed ID: 28098593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary recommendations for dysbetalipoproteinemia: A need for better evidence.
    Paquette M; Blais C; Fortin A; Bernard S; Baass A
    J Clin Lipidol; 2023; 17(4):549-556. PubMed ID: 37268489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of Diagnostic Criteria and High Prevalence of Familial Dysbetalipoproteinemia in Russia: A Pilot Study.
    Blokhina AV; Ershova AI; Kiseleva AV; Sotnikova EA; Zharikova AA; Zaicenoka M; Vyatkin YV; Ramensky VE; Kutsenko VA; Shalnova SA; Meshkov AN; Drapkina OM
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemic myeloma, a rare form of acquired dysbetalipoproteinemia, in an HIV seropositive African female.
    Seedat F; Patel M; Phillip V; Mohamed F; Marais AD; Blackhurst DM; Solomon G; Currin S; Raal FJ
    Clin Chim Acta; 2021 Sep; 520():71-75. PubMed ID: 34052205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
    Heidemann BE; Koopal C; Baass A; Defesche JC; Zuurbier L; Mulder MT; Roeters van Lennep JE; Riksen NP; Boot C; Marais AD; Visseren FLJ
    Clin Genet; 2022 Oct; 102(4):253-261. PubMed ID: 35781703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and laboratory investigation of dysbetalipoproteinemia.
    Boot CS; Luvai A; Neely RDG
    Crit Rev Clin Lab Sci; 2020 Nov; 57(7):458-469. PubMed ID: 32255405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbetalipoproteinemia: an extreme disorder of remnant metabolism.
    Marais D
    Curr Opin Lipidol; 2015 Aug; 26(4):292-7. PubMed ID: 26103610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease.
    Koopal C; van der Graaf Y; Asselbergs FW; Westerink J; Visseren FL;
    Int J Obes (Lond); 2015 Feb; 39(2):265-9. PubMed ID: 24946908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbetalipoproteinemia: Two cases report and a diagnostic algorithm.
    Kei A; Miltiadous G; Bairaktari E; Hadjivassiliou M; Cariolou M; Elisaf M
    World J Clin Cases; 2015 Apr; 3(4):371-6. PubMed ID: 25879010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohorts.
    Heidemann BE; Wolters FJ; Kavousi M; Gruppen EG; Dullaart RP; Marais AD; Visseren FL; Koopal C
    Atherosclerosis; 2021 May; 325():57-62. PubMed ID: 33892328
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.